Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice
    Published on 2026-01-19
    4 months ago
  • Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [18F]Flubatine PET images
    Published on 2026-01-19
    4 months ago
  • Modulation of accumbens dopamine by MCH neurons during learning and consummatory behavior
    Published on 2026-01-18
    4 months ago
  • Excitation–inhibition homeostasis in Alzheimer’s disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities
    Published on 2026-01-18
    4 months ago
  • Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future
    Published on 2026-01-18
    4 months ago
  • Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia
    Published on 2026-01-16
    4 months ago
  • Neuromodulation and cognition in late-life depression
    Published on 2026-01-16
    4 months ago
« Previous 1 … 16 17 18 19 20 … 143 Next »
Journal of Psychopharmacology
  • Incident benzodiazepine and Z-drug use and subsequent risk of alcohol- and drug-related problems: A nationwide matched cohort study with co-twin comparison
    Published on 2025-10-02
    8 months ago
  • Disrupted network integrity and therapeutic plasticity in drug-naive panic disorders: Insights from network homogeneity
    Published on 2025-10-02
    8 months ago
  • No differences in neural responses or performance during cannabis cue-specific inhibitory control tasks between recreational cannabis users and non-users: Insights from fNIRS
    Published on 2025-10-02
    8 months ago
  • Hypnotics and Suicide: A Tangled Web
    Published on 2025-09-30
    8 months ago
  • Escitalopram and functional connectivity in major depressive disorder: A systematic review
    Published on 2025-09-30
    8 months ago
  • Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999–2024: An update report to inform the reclassification debate
    Published on 2025-09-29
    8 months ago
  • The effects of antenatal depression and SSRI exposure on children: A systematic review
    Published on 2025-09-25
    8 months ago
« Previous 1 … 16 17 18 19 20 … 146 Next »
European Neuropsychopharmacology
  • Reply to Jianjie Ju and Hui Chen
    Published on 2025-09-22
    8 months ago
  • The potential of applying large-scale multi-omics data to unsupervised learning-based transdiagnostic clusters of individuals with severe mental disorders to identify pharmacodynamic targets
    Published on 2025-09-21
    8 months ago
  • Editorial Board
    Published on 2025-09-17
    8 months ago
  • Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations
    Published on 2025-09-09
    9 months ago
  • Methodological gaps in treatment-resistant depression prediction
    Published on 2025-09-05
    9 months ago
  • Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis
    Published on 2025-09-01
    9 months ago
  • Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations
    Published on 2025-08-29
    9 months ago
« Previous 1 … 16 17 18 19 20 … 166 Next »

   Pharma Pub